Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Volumetric Analysis) | min. 95.0 % |
Water | max. 5.0 % |
NMR | confirm to structure |
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile
Purity / Analysis Method | >95.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C26H29Cl2N5O3 = 530.45 |
Physical State (20 deg.C) | Solid |
CAS RN | 380843-75-4 |
Unit | Price |
100 mg | 4975 |
250 mg | 5500 |
1 g | 10125 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Volumetric Analysis) | min. 95.0 % |
Water | max. 5.0 % |
NMR | confirm to structure |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|